Oct 14, 2022
To combat COVID-19, parts of Asia continue to implement a zero-COVID strategy. The strategy means strict lockdowns, travel disruptions and more. And the impact to site-centric clinical trials is significant.
Many organizations conducting clinical trials in Asia are moving to a patient-centric clinical trial model. To offer direct-to-patient and direct-from-patient shipping in this model means a shift in how temperature control is managed, including less use of temperature-controlled vehicles and more use of easy-to-use temperature-controlled packaging.
To learn more about the clinical trials changes happening in Asia, check out the most recent issue of the Journal for Clinical Studies.
Image
![Cell and Gene sample collection](/sites/default/files/styles/page_image/public/2021-08/Peli%20BioThermal%20cell%20and%20gene%20%281%29.jpg?itok=TSqy_-32)